Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

The Restorative Role of Daytime Naps in Mentally Fatigued Endurance Athletes (Nap&Run)

5 mei 2026 bijgewerkt door: Jacopo Vitale, L.U.de.S. Sagl

The Restorative Role of Daytime Naps in Mentally Fatigued Endurance Athletes: a Randomized Controlled Trial

This randomized, counterbalanced crossover study investigated whether a 30-minute daytime nap can mitigate the effects of experimentally induced mental fatigue in amateur master endurance athletes. Male athletes completed two home-based experimental sessions separated by one week: a mental fatigue condition, in which a 30-minute cognitively demanding task battery preceded the nap, and a control condition, in which participants took only the nap. Sleep parameters during the nap were monitored by wrist actigraphy, and perceived sleep quality was assessed after awakening. Subjective sleepiness, perceived mental fatigue, and cognitive performance were evaluated before the nap, immediately after the nap, and/or 30 minutes after the nap.

The study examined whether mental fatigue influenced nap characteristics and whether the nap improved recovery-related outcomes. The main outcomes included actigraphy-derived nap parameters, perceived sleep quality, sleepiness assessed with the Karolinska Sleepiness Scale, perceived mental fatigue assessed using a visual analogue scale, and cognitive performance assessed with a Flanker task.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Werkelijk)

11

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

      • Milan, Italië
        • University of Milan

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Male amateur master endurance athletes
  • Age between 28 and 50 years
  • Peak oxygen uptake (VO₂peak) ≥55 mL·kg-¹·min-¹
  • Habitual nocturnal sleep duration of at least 7 hours
  • Able and willing to complete both experimental sessions and daytime nap procedures

Exclusion Criteria:

  • Diagnosed medical condition or injury
  • Diagnosed sleep disorder
  • Use of medications or supplements affecting sleep or cognition, including melatonin
  • Habitual sleep duration of less than 7 hours per night
  • Inability to nap during the experimental sessions

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Crossover-opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Experimenteel: Mental Fatigue + Daytime Nap
Participants completed a 30-minute mental fatigue induction protocol consisting of cognitively demanding tasks, followed by a 30-minute daytime nap performed at home between 14:00 and 15:00. Subjective sleepiness, perceived mental fatigue, nap characteristics, perceived sleep quality, and cognitive performance were assessed before and/or after the nap.
Participants completed a 30-minute computerized cognitive task battery designed to induce mental fatigue before the daytime nap. The protocol consisted of three consecutive 10-minute cognitively demanding tasks: a Flanker task, a memory task, and a Stroop task.
Participants took a 30-minute daytime nap at home between 14:00 and 15:00, at least one hour after lunch, in a quiet and dimly lit room. Nap characteristics were monitored using wrist actigraphy, and perceived sleep quality was assessed after awakening.
Actieve vergelijker: Daytime Nap Control
Participants completed the control condition consisting of a 30-minute daytime nap performed at home between 14:00 and 15:00, without the preceding mental fatigue induction protocol. Subjective sleepiness, perceived mental fatigue, nap characteristics, perceived sleep quality, and cognitive performance were assessed before and/or after the nap.
Participants took a 30-minute daytime nap at home between 14:00 and 15:00, at least one hour after lunch, in a quiet and dimly lit room. Nap characteristics were monitored using wrist actigraphy, and perceived sleep quality was assessed after awakening.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Perceived mental fatigue
Tijdsspanne: Before the nap, immediately after the nap, and 30 minutes after the nap in each experimental condition.
Perceived mental fatigue was assessed using a 100-mm visual analogue scale for mental fatigue (VAS-MF), anchored from 0-mm "No mental fatigue" to 100-mm "Maximum mental fatigue." Participants marked the point that best represented their perceived level of mental fatigue.
Before the nap, immediately after the nap, and 30 minutes after the nap in each experimental condition.

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Subjective sleepiness
Tijdsspanne: Before the nap, immediately after the nap, and 30 minutes after the nap
Subjective sleepiness was assessed using the Karolinska Sleepiness Scale (KSS), a 9-point scale ranging from 1, "not sleepy at all," to 9, "extremely sleepy."
Before the nap, immediately after the nap, and 30 minutes after the nap
Flanker Task Reaction Time
Tijdsspanne: 30 minutes after the nap in each experimental condition.
Accuracy during the computerized Flanker task was calculated as the percentage of correct responses and used as an indicator of executive function performance. Accuracy ranges from 0 to 100%.
30 minutes after the nap in each experimental condition.
Perceived Nap Sleep Quality
Tijdsspanne: Immediately after the nap in each experimental condition.
Perceived sleep quality after the nap was assessed using a 10-point Likert scale, from 0 to 10, with higher scores indicating better perceived sleep quality.
Immediately after the nap in each experimental condition.
Actigraphy-Derived nap start time
Tijdsspanne: During the 30-minute daytime nap in each experimental condition.
Clock time at which the nap period begins, usually identified from the rest interval or sleep diary. Nap start time is expressed as clock time, using the 24-hour format.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap time in bed
Tijdsspanne: During the 30-minute daytime nap in each experimental condition.
Total time spent in bed or within the defined nap/rest interval, from nap start time to nap end time. Values are expressed in minutes.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap total sleep time
Tijdsspanne: During the 30-minute daytime nap in each experimental condition.
Total duration of epochs scored as sleep during the nap/rest interval. Values are expressed in minutes.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap sleep onset latency
Tijdsspanne: During the 30-minute daytime nap in each experimental condition.
Time elapsed between nap start time and the first epoch scored as sleep. Values are expressed in minutes.
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap sleep efficiency
Tijdsspanne: During the 30-minute daytime nap in each experimental condition.
Sleep efficiency is expressed as a percentage, ranging from 0% to 100%, and is calculated as the ratio between total sleep time and time in bed multiplied by 100
During the 30-minute daytime nap in each experimental condition.
Actigraphy-Derived nap fragmentation index
Tijdsspanne: During the 30-minute daytime nap in each experimental condition.
An index reflecting sleep disruption or restlessness, based on movement and short immobility bouts during the sleep period. Higher values indicate more fragmented sleep. Fragmentation index is expressed as a percentage from 0% to 100%
During the 30-minute daytime nap in each experimental condition.

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

11 januari 2021

Primaire voltooiing (Werkelijk)

15 mei 2021

Studie voltooiing (Werkelijk)

15 mei 2021

Studieregistratiedata

Eerst ingediend

28 april 2026

Eerst ingediend dat voldeed aan de QC-criteria

5 mei 2026

Eerst geplaatst (Werkelijk)

12 mei 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

12 mei 2026

Laatste update ingediend die voldeed aan QC-criteria

5 mei 2026

Laatst geverifieerd

1 mei 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Individual participant data will not be made publicly available. Data supporting the findings of this study may be available from the corresponding author upon reasonable request.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren